Cargando...

Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis

T-705 (favipiravir) is a new antiviral agent in advanced clinical development for influenza therapy. It is supposed to act as an alternative substrate for the viral polymerase, causing inhibition of viral RNA synthesis or virus mutagenesis. These mechanisms were also proposed for ribavirin, an estab...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Vanderlinden, Evelien, Vrancken, Bram, Van Houdt, Jeroen, Rajwanshi, Vivek K., Gillemot, Sarah, Andrei, Graciela, Lemey, Philippe, Naesens, Lieve
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2016
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5075073/
https://ncbi.nlm.nih.gov/pubmed/27572398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01156-16
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!